High Flow Therapy in ICUs Across Ibero America
- Conditions
- HypoxiaHypercapnic Respiratory FailureVentilatory FailureNasal High Flow TherapyIntensive Care Unit
- Registration Number
- NCT03364946
- Lead Sponsor
- Fundación Santa Fe de Bogota
- Brief Summary
The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of participating centers in Iberoamerica. It will describe the indications for the use, the clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying in an intensive care unit in the participant centers in Iberoamerica.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 255
- Over 18 years old
- Admitted to medical or surgical ICU
- Requirement of high nasal flow therapy
- Post-extubation failure
- Patient unable to protect airway
- Diagnosed shock
- Glasgow equal or under 8
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypoxemia 15 days PO2 under 60mmHg, or SatO2 under 80%; that leads to the instauration of invasive ventilation
Tachypnea 15 days Respiratory rate over 20; that leads to the instauration of invasive ventilation
Hypercapnia 15 days PCO2 over 55mmHg; that leads to the instauration of invasive ventilation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
Fundación Santa Fe de Bogotá
🇨🇴Bogota, Bogotá, Colombia
Hospital Departamental de Nariño
🇨🇴Nariño, Pasto, Colombia
Medicina Intensiva del Tolima
🇨🇴Ibague, Tolima, Colombia
Clinica Reina Sofia
🇨🇴Bogota, Colombia
Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavarez (INCART)
🇩🇴Santo Domingo, Dominican Republic
Fundación Medica Sur
🇲🇽Ciudad de mexico, Ciudad De México, Mexico
Hospital del Mar - Parc de Salut Mar
🇪🇸Barcelona, Spain
MD Anderson Cancer Center
🇪🇸Madrid, Spain
Hospital Ramon y Cajal
🇪🇸Madrid, Spain
Fundación Santa Fe de Bogotá🇨🇴Bogota, Bogotá, Colombia